IQVIA Holdings Inc at William Blair Growth Stock Conference Transcript
I'm John Kreger, the analyst at William Blair that follows IQVIA and the pharma services space in general. I am required to tell you that you can get a full list of our research disclosures or potential conflicts at williamblair.com.
So here from the company today is Ari Bousbib, the CEO; as well as Andrew Markwick, the Head of IR. We're going to do it a little differently than our traditional setup. We're going to do this more as a fireside chat over the next half an hour. And then for anyone that wants to continue the Q&A, we will do a breakout starting at 11:20 upstairs in the Maher Room. So thank you all for coming.
Questions & Answers
Ari, maybe I'll get started with a general one. If you can kind of step back to the merger announcement with Quintiles, maybe just give us a refresher. What was the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
